TGSafe® Whole Exome Genetic Test
Application
Human genome includes more than 20,000 genes. Whole exome sequencing detects SNP and small indels. The applications are:
- Pediatric diseases
- Neurological diseases
- Various genetic diseases
Why Choose TGSafe®?
When it is suspected to be a genetic disease, we can help you
- Identify disease-causing genes
- Choose the right treatment
- Optimize patient care process
- Plan the eugenics program
Authorized by the National Health Research Institutes, the entire sequencing service is done in Taiwan
The sequencing techniques were transferred from the National Health Research Institutes. TGIA provides comprehensive gene annotation reports.
- TGIA is the only authorized company to use whole exome sequencing technology and bioinformatics analysis process, as well as nearly 5,000 Taiwanese WES/WGS cases of disease database.
- WES detects more than 20,000 genes from Human genome.
- The entire sequencing service is done in Taiwan.
International designated use with highest quality certification
100,000 reported disease data with verification and NHS designated use
- Use the world’s highest standard Congenica gene interpretation platform
- Validated for 100,000 rare disease gene databases in Europe and America, with the highest detection rate in the world
- The only clinical decision-making assistance platform included in the National Medical Insurance System of the UK National Health Service.
- The world’s only CE IVD certified interpretation system, and has the world’s most quality certification.
Service Process
Gene Interpretation Process
